Practice Director - Life Sciences
Ms. Illuri is a career pharma R&D management consultant, patient advocate and an aspiring author.
Over her 20-year global career in the life sciences and healthcare industry, she has both advised and worked for pharma corporations on enterprise-wide business transformation initiatives. Her core expertise is in operational aspects of a) drug safety b) medical affairs/information, C) patient-centricity c) international regulatory compliance d) adoption strategies for Process Automation, Analytics, and Artificial Intelligence. Her past employers and clients include the big 4 consulting (Ernst &Young, Deloitte), and big pharma (Roche, Novartis, Genentech, Abbott Labs).
Interim COO Services – Currently providing interim COO services to an early-stage, drug discovery company. This involves translating medicinal discoveries into product commercialization. Activities include commercial entity formation, product pipeline review, gap analysis (pre-IND activities) asset valuation, capital funding strategies and partnerships.
Global process harmonization – Led consulting teams to harmonize PV processes globally (51 affiliates) and implement an enterprise-wide system for two big-pharma clients in Chicago and Switzerland.
Strategic sourcing of CRO partners – Re-negotiated global, multi-year master services agreements for central labs supplies (budget of $100M) for a top 5 pharma based in Switzerland. Resulted in 24% immediate savings. Engagement required senior stakeholder buy-in and organization-wide change management.
Assessed impact of emerging drug safety regulations from FDA, MHRA, and EMA. Specifically, on SENTINEL and GVP Module IX – Signal Management.
“You are exactly where you need to be” – Unknown
“Ancora Imparo (Yet I am learning)” – Michelangelo at the age of 84